---
title: "HAID GROUP, VTR and other newly established biotechnology companies"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/257022005.md"
description: "According to the Qichacha APP, recently, Guangdong Haituo Biotechnology Co., Ltd. was established with a registered capital of 35 million yuan. The business scope includes: environmental protection monitoring; production, sales, processing, transportation, storage of agricultural products, and other related services. Qichacha's equity penetration shows that the company is jointly held by HAID GROUP, VTR, and others"
datetime: "2025-09-12T03:21:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/257022005.md)
  - [en](https://longbridge.com/en/news/257022005.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/257022005.md)
generator: "portal-rs"
---

# HAID GROUP, VTR and other newly established biotechnology companies

According to the Qichacha APP, recently, Guangdong Haituo Biotechnology Co., Ltd. was established with a registered capital of 35 million yuan. Its business scope includes: environmental protection monitoring; production, sales, processing, transportation, storage of agricultural products, and other related services. Qichacha's equity penetration shows that the company is jointly held by HAID GROUP, VTR, and others

### Related Stocks

- [002311.CN](https://longbridge.com/en/quote/002311.CN.md)
- [300381.CN](https://longbridge.com/en/quote/300381.CN.md)

## Related News & Research

- [EXPLAINER-Haiti's conflict in numbers as gangs inflict another night of terror](https://longbridge.com/en/news/297076683.md)
- [BIDU-SW  to Pursue Dual Primary Listing on HKEX and Nasdaq Starting Next Tue](https://longbridge.com/en/news/297102765.md)
- [MSC halts Russian Black Sea service after drone attack, Bloomberg News reports](https://longbridge.com/en/news/297066548.md)
- [09:02 ETEnchanting Travels Elevates the Art of Luxury Custom Travel by Going "Beyond the Prompt"](https://longbridge.com/en/news/297050359.md)
- [Heidelberg Pharma says China NMPA clears HDP-101 combo trial in multiple myeloma](https://longbridge.com/en/news/297070749.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**